Citation: Ll. Licato et al., A novel preclinical model of human malignant melanoma utilizing bioreactorrotating-wall vessels, IN VITRO-AN, 37(3), 2001, pp. 121-126
Authors:
Ekmekcioglu, S
Ellerhorst, J
Mhashilkar, AM
Sahin, AA
Read, CM
Prieto, VG
Chada, S
Grimm, EA
Citation: S. Ekmekcioglu et al., Down-regulated melanoma differentiation associated gene (MDA-7) expressionin human melanomas, INT J CANC, 94(1), 2001, pp. 54-59
Authors:
Ekmekcioglu, S
Ellerhorst, J
Smid, CM
Prieto, VG
Munsell, M
Buzaid, AC
Grimm, EA
Citation: S. Ekmekcioglu et al., Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival, CLIN CANC R, 6(12), 2000, pp. 4768-4775
Authors:
Grimm, EA
Smid, CM
Lee, JJ
Tseng, CH
Eton, O
Buzaid, AC
Citation: Ea. Grimm et al., Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy, CLIN CANC R, 6(10), 2000, pp. 3895-3903
Citation: Eg. Caudell et al., Characterization of human copine III as a phosphoprotein with associated kinase activity, BIOCHEM, 39(42), 2000, pp. 13034-13043
Authors:
Ekmekcioglu, S
Okcu, MF
Colome-Grimmer, MI
Owen-Schaub, L
Buzaid, AC
Grimm, EA
Citation: S. Ekmekcioglu et al., Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10, MELANOMA RE, 9(3), 1999, pp. 261-272
Citation: Ek. Robinson et al., Correlation of interleukin 6 with interleukin 1 alpha in human mammary tumours, but not with oestrogen receptor expression, CYTOKINE, 10(12), 1998, pp. 970-976